Skip to main content
Premium Trial:

Request an Annual Quote

Foss Subsidiary to Distribute Warnex Detection Systems in UK, Ireland

NEW YORK, May 16 (GenomeWeb News) - Warnex said yesterday that Foss UK, a subsidiary of Danish firm Foss, will distribute and market Warnex's Rapid Pathogen Detection System in the UK and Ireland.


Foss UK, based in Warrington, will replace Warnex's previous distributor, Don Whitley Scientific.


Additional terms were not disclosed.


The Rapid Pathogen Detection System uses DNA-based technology to determine the presence of pathogens in a sample.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.